One Health and vaccine ecosystems at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

21 organizations at World Vaccine Congress Europe 2026 present work in one health & ecosystems: 11 public-health and non-profit bodies, 5 academic bodies, 3 vaccine and drug developers and 2 suppliers and service providers. Between them they bring 39 presentations to the program. Most represented: European Commission (5 on the program), UK Health Security Agency (UKHSA) (2 on the program), DIOSynVax (2 on the program). 9 of them have their own page in this guide. As of Sep 26, 2026.

All 251 organizations at World Vaccine Congress Europe 2026 →

Format
Top represented
Showing 1–13 of 21 organizations
OrganizationWorld Vaccine Congress Europe 2026 Attendance
European Commission
Brussels, Belgium
Public health & non-profit
Executive body of the European Union, setting EU health, health-security and veterinary policy.
Panel
Tue Oct 20
17:10
One Health in Action: Connecting Human, Animal, and Environmental Health to Advance Vaccine Strategy
How tracking disease in people, animals and the environment together can set vaccine priorities for infections that jump from animals, like bird flu.
with Food and Agriculture Organization (FAO), Lyonbiopole, World Organisation for Animal Health (WOAH) +1 more
One Health & ecosystems
Talk
Wed Oct 21
09:00
The New Geopolitics of Vaccines: Global Vaccine Manufacturing in a Fractured World
How governments and industry can keep vaccines flowing fairly across borders in an emergency as countries push to make vaccines at home.
with Hilleman Laboratories, Access to Medicine Foundation, UNICEF +2 more
Supply, safety & accessBioprocess & manufacturing
Talk
Wed Oct 21
10:45
Panel
Wed Oct 21
11:00
Panel: Rethinking Livestock Vaccination for Emerging Threats
How to speed new livestock vaccines against diseases that can jump to people, weighing approval rules, food safety, trade and funding incentives.
with Boehringer Ingelheim, World Organisation for Animal Health (WOAH), SciEthiQ +1 more
Talk
Wed Oct 21
12:15
Panel: The New Geography of Vaccine Innovation: Why the Next Decade of Vaccine Development Will Be Driven by LMICs
Why low- and middle-income countries are becoming vaccine innovators, not just trial sites, and what funding and regional regulatory cooperation they need.
with Hilleman Laboratories, International Vaccine Institute, Luipaard
Panel
Wed Oct 21
16:00
Europe’s Vision for Global Health Security: Designing Sustainable Vaccine Financing and Preparedness Systems
How Europe can shift vaccine funding from crisis-driven spending to long-term plans, using tools like joint purchasing and advance promises to buy.
with University of Groningen, CEPI, UK Department of Health and Social Care +1 more
Supply, safety & access
Public health & non-profit
UK agency that plans for, prevents and responds to health threats, providing scientific and operational leadership nationally and globally.
Booth
Exhibiting at Booth 417
Talk
Mon Oct 19
16:15
Panel: From Early Signals to Decisions: The Future of Outbreak Intelligence
How genome sequencing, wastewater testing and health records can flag outbreaks early enough to guide vaccine strain choice and policy.
with PATH, Erasmus MC, Moderna +1 more
Panel
Tue Oct 20
17:10
One Health in Action: Connecting Human, Animal, and Environmental Health to Advance Vaccine Strategy
How tracking disease in people, animals and the environment together can set vaccine priorities for infections that jump from animals, like bird flu.
with Food and Agriculture Organization (FAO), Lyonbiopole, European Commission +1 more
One Health & ecosystems
Panel
Wed Oct 21
10:45
Panel: Emerging Outbreaks at the Front Line: From Early Signals to Real-World Response
How outbreaks like bird flu and hantavirus can be spotted sooner, what vaccines add to the response, and where gaps remain.
with CSL Seqirus, University of Oxford, GSK +1 more
Panel
Wed Oct 21
13:30
Panel: Controlled Human Infection Models (CHIMs): Evidence, Ethics and the Next Phase of Vaccine R&D
How studies that deliberately infect volunteers guide vaccine decisions, and what must be in place before using them for new diseases.
with CEPI, International Vaccine Institute, Centre for Human Drug Research (CHDR) +1 more
DIOSynVax
Cambridge, United Kingdom
Biotech
Uses computational antigen design to develop broadly protective vaccines against influenza, coronaviruses and other viral threats.
Talk
Mon Oct 19
11:15
AI designed universal vaccine technology to prevent future virus outbreaks
Workshop: Platform Technologies
Talk
Tue Oct 20
14:00
Track Chair
Technology Showcases
Talk
Tue Oct 20
16:00
Track Chair
Technology Showcases
Talk
Wed Oct 21
13:45
Next Generation vaccines to prevent cross-species transmission of Influenza
One Health & Veterinary
Public health & non-profit
Intergovernmental organization setting animal health standards, including for veterinary vaccines and livestock vaccination.
Panel
Tue Oct 20
17:10
One Health in Action: Connecting Human, Animal, and Environmental Health to Advance Vaccine Strategy
How tracking disease in people, animals and the environment together can set vaccine priorities for infections that jump from animals, like bird flu.
with Food and Agriculture Organization (FAO), Lyonbiopole, European Commission +1 more
One Health & ecosystems
Panel
Wed Oct 21
11:00
Panel: Rethinking Livestock Vaccination for Emerging Threats
How to speed new livestock vaccines against diseases that can jump to people, weighing approval rules, food safety, trade and funding incentives.
with Boehringer Ingelheim, SciEthiQ, VIDO (Vaccine and Infectious Disease Organization) +1 more
Panel
Wed Oct 21
13:15
Panel: Rethinking AMR Priorities: Choosing the Targets That Move the Needle
How to choose which drug-resistant bacteria to target with vaccines and antibody drugs, using cost-effectiveness models to line up funders and drugmakers.
with World Health Organization (WHO), PATH, IAVI +2 more
Talk
Wed Oct 21
15:30
Why the highest-leverage move against AMR may not be a human vaccine at all…
One Health & Veterinary
VG
The Vaccine Group
Biotech
Develops vaccines against zoonotic and animal diseases using herpesvirus vectors.
Chair
Wed Oct 21
10:30
Chair’s opening remarks
One Health & Veterinary
CRO, CDMO & labs
Contract research organization for infectious disease and zoonoses research, offering bioanalytical services and preclinical studies; part of GD Group.
Booth
Exhibiting at Booth 413
Talk
Tue Oct 20
16:15
Boehringer Ingelheim
Ingelheim am Rhein, Germany
Large pharma
Pharmaceutical company whose animal health business makes livestock and companion-animal vaccines.
Panel
Wed Oct 21
11:00
Panel: Rethinking Livestock Vaccination for Emerging Threats
How to speed new livestock vaccines against diseases that can jump to people, weighing approval rules, food safety, trade and funding incentives.
with World Organisation for Animal Health (WOAH), SciEthiQ, VIDO (Vaccine and Infectious Disease Organization) +1 more
Talk
Wed Oct 21
13:15
Efficacy of Early Vaccination Against Avian Influenza in Commercial Poultry
One Health & Veterinary · with Wageningen University & Research
Public health & non-profit
United Nations agency for food and agriculture, including animal health and One Health work on zoonotic diseases.
Panel
Tue Oct 20
17:10
One Health in Action: Connecting Human, Animal, and Environmental Health to Advance Vaccine Strategy
How tracking disease in people, animals and the environment together can set vaccine priorities for infections that jump from animals, like bird flu.
with Lyonbiopole, European Commission, World Organisation for Animal Health (WOAH) +1 more
One Health & ecosystems
Talk
Wed Oct 21
14:30
Panel: Bridging Species: Veterinary Vaccine Innovation for a Shared Health Future
How vaccine technologies like mRNA can be adapted, made and approved for livestock and wildlife, and how animal vaccines could reduce antimicrobial use.
with GALVmed, ICARS, University of Veterinary Medicine Hannover +1 more
Talk
Mon Oct 19
14:15
Panel: Preparing for Disease X: Approaches for the Next Spillover
How to spot the next unknown disease jumping from animals to people early, and how vaccines could be readied or stockpiled beforehand.
with University of North Carolina at Chapel Hill, The Francis Crick Institute, Foundation for the National Institutes of Health +1 more
Talk
Wed Oct 21
14:30
Panel: Bridging Species: Veterinary Vaccine Innovation for a Shared Health Future
How vaccine technologies like mRNA can be adapted, made and approved for livestock and wildlife, and how animal vaccines could reduce antimicrobial use.
with Food and Agriculture Organization (FAO), GALVmed, ICARS +1 more
Academic
University of Saskatchewan research organization developing vaccines and technologies against human and animal infectious diseases.
Booth
Exhibiting at Booth 312
Panel
Wed Oct 21
11:00
Panel: Rethinking Livestock Vaccination for Emerging Threats
How to speed new livestock vaccines against diseases that can jump to people, weighing approval rules, food safety, trade and funding incentives.
with Boehringer Ingelheim, World Organisation for Animal Health (WOAH), SciEthiQ +1 more
FA
Federal Agency for Medicines and Health Products (FAMHP)
Brussels, Belgium
Public health & non-profit
Belgium's medicines regulator (FAGG in Dutch), overseeing clinical trials and medicines including vaccines.
Talk
Wed Oct 21
13:40
Belgium as a Vaccine Clinical Trials Hub: Fast, Reliable Clinical Trials in a Strong Regulatory Ecosystem
How Belgium's national regulators attract vaccine clinical trials and how the country has performed since the EU's clinical trial rules took effect.
FB
Fondazione Biotecnopolo di Siena
Siena, Italy
Public health & non-profit
Italian public foundation building a national life sciences hub and anti-pandemic centre for vaccine and preparedness research.
FB
France BioLead
Public health & non-profit
French biomanufacturing industry network.
Talk
Wed Oct 21
13:10
Vaccine & beyond : the power of an integrated biomanufacturing ecosystem
International Bioclusters

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers in one health & ecosystems

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse World Vaccine Congress Europe 2026 by

Exhibit hall

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction